Trial Design Webinars

  1. Is Your Clinical Supply Playbook Ready for Phase II and Beyond?

    Understand certain study characteristics can act as useful leading indicators of future clinical supply challenges, allowing clinical sponsors to take a proactive rather than reactive approach to clinical supplies.

  2. Leverage An Asia-Pacific Network To Create Regional Efficiencies In Clinical Supply Management

    Clinical packaging, logistics and import/export considerations that should be taken into account when developing a clinical supply strategy in China, Singapore and Japan.

  3. Navigating Clinical Supply Challenges In Emerging Regions

    Don't let the complex logistics involved in the handling of clinical supplies in certain regions of the world put your patients at risk or jeopardize both the study budget and timeline.

  4. Demand Led Services and Clinical Supply Efficiency

    See how this service can benefit you with shorter lead time, less waste, less stock out risk and no booklet labels.

  5. Planning And Conducting Trials Of The Latest Immunotherapies

    In this webinar, INC Research/inVentiv Health experts discuss the factors that sponsors must take into account as they design and execute clinical trials in this space, beginning with a review of the immunotherapy landscape.

  6. Logistics Leaders - How To Successfully Ship Cell And Gene Therapies

    Hear insights from Sam Herbert, president of World Courier, regarding how the evolution of the supply chain in traditional small and large molecules is a handoff from clinical partners into commercial partners.

  7. Evidence-Based Approaches For Accelerating Patient Enrollment In Oncology

    The number of oncology clinical trials has increased exponentially in recent years, putting ever more pressure on increasing clinical trial efficiency by reducing costs and timelines. Patient recruitment swallows 40% of trial costs, yet only 10–17% of studies enroll on time and approximately 11% of sites in any given study fail to enroll a single patient.

  8. Rare and Orphan Diseases Patient Perceptions

    Do you face the challenge of recruiting and retaining rare disease patients for orphan drug clinical trials? Now, discover how you can boost participation, enhance outcomes and speed drug development in this competitive market.

  9. How eConsent Improves Consent Development

    Developing informed consent content requires a lot of back and forth communication between multiple stakeholders - an inefficient, slow process with a history of allowing unapproved or out-of-date consents to be accidentally deployed to sites. Electronic Informed Consent (eConsent) offers a streamlined, collaborative process that promotes faster content development, approval and deployment on one platform, guaranteeing that only the most current and approved consent version is used each time.

  10. The Value Of Electronic Informed Consent

    Securing informed consent from clinical trial participants involves more than a signature—you need to ensure participants truly understand what they’re signing.  Learn from industry expert, Sandra “SAM” Sather, on how the electronic informed consent (eConsent) process improves the way participants are consented on a clinical trial.